cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.
Company profile
Ticker
CAH
Exchange
Website
CEO
Michael Kaufmann
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CARDINAL DISTRIBUTION INC
SEC CIK
Corporate docs
Subsidiaries
A+ Secure Packaging, LLC • Aero-Med, LLC • Allegiance Corporation • Cardinal Health 2, LLC • Cardinal Health 3, LLC • Cardinal Health 5, LLC • Cardinal Health 6, Inc. • Cardinal Health 7, LLC • Cardinal Health 100, LLC • Cardinal Health 104 LP ...
IRS number
310958666
CAH stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
23 Apr 24
8-K
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
22 Apr 24
8-K
Departure of Directors or Certain Officers
28 Feb 24
8-K
Entry into a Material Definitive Agreement
20 Feb 24
424B5
Prospectus supplement for primary offering
16 Feb 24
FWP
Free writing prospectus
14 Feb 24
424B5
Prospectus supplement for primary offering
14 Feb 24
10-Q
2024 Q2
Quarterly report
1 Feb 24
8-K
Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
1 Feb 24
8-K
Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update
9 Jan 24
Transcripts
CAH
Earnings call transcript
2024 Q2
1 Feb 24
CAH
Earnings call transcript
2024 Q1
3 Nov 23
CAH
Earnings call transcript
2023 Q4
15 Aug 23
CAH
Earnings call transcript
2023 Q3
4 May 23
CAH
Earnings call transcript
2023 Q2
2 Feb 23
CAH
Earnings call transcript
2023 Q1
4 Nov 22
CAH
Earnings call transcript
2022 Q4
11 Aug 22
CAH
Earnings call transcript
2022 Q3
5 May 22
CAH
Earnings call transcript
2022 Q2
3 Feb 22
CAH
Earnings call transcript
2022 Q1
9 Nov 21
Latest ownership filings
4
Michelle D. Greene
18 Mar 24
4
Robert Azelby
18 Mar 24
3
Robert Azelby
1 Mar 24
4
Aaron E Alt
16 Feb 24
4
Michelle D. Greene
16 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
STATE STREET CORP
30 Jan 24
SC 13G/A
BlackRock Inc.
24 Jan 24
144
Notice of proposed sale of securities
20 Dec 23
4
Ola M Snow
5 Dec 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.85 bn | 3.85 bn | 3.85 bn | 3.85 bn | 3.85 bn | 3.85 bn |
Cash burn (monthly) | 63.00 mm | (no burn) | 8.67 mm | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 431.38 mm | n/a | 59.34 mm | n/a | n/a | n/a |
Cash remaining | 3.42 bn | n/a | 3.79 bn | n/a | n/a | n/a |
Runway (months of cash) | 54.3 | n/a | 437.8 | n/a | n/a | n/a |
Institutional ownership, Q3 2023
86.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 926 |
Opened positions | 92 |
Closed positions | 77 |
Increased positions | 305 |
Reduced positions | 374 |
13F shares | Current |
---|---|
Total value | 18.18 tn |
Total shares | 209.64 mm |
Total puts | 1.98 mm |
Total calls | 2.54 mm |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 32.09 mm | $2.79 tn |
BLK Blackrock | 28.03 mm | $2.43 tn |
STT State Street | 14.64 mm | $1.27 tn |
FMR | 5.97 mm | $518.37 bn |
Arrowstreet Capital, Limited Partnership | 5.80 mm | $504.42 bn |
Geode Capital Management | 5.49 mm | $475.63 bn |
MS Morgan Stanley | 4.42 mm | $383.44 bn |
AMP Ameriprise Financial | 4.13 mm | $358.39 bn |
IVZ Invesco | 3.47 mm | $301.10 bn |
NTRS Northern Trust | 3.34 mm | $290.03 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Azelby Robert | Common Shares | Grant | Acquire A | No | No | 0 | 1,288 | 0.00 | 1,288 |
15 Mar 24 | Michelle D. Greene | Common Shares | Payment of exercise | Dispose F | No | No | 109.93 | 664 | 72.99 k | 19,486 |
15 Feb 24 | Michelle D. Greene | Common Shares | Payment of exercise | Dispose F | No | No | 103.55 | 664 | 68.76 k | 20,150 |
15 Feb 24 | Alt Aaron E | Common Shares | Payment of exercise | Dispose F | No | No | 103.55 | 1,919 | 198.71 k | 27,400 |
News
Philips' Zenition 30 to Boost Image-Guided Surgeries
23 Apr 24
Stocks Set To Snap Worst Losing Streak In Nearly 2 Years, Gold Sinks, Bitcoin Reclaims $66,000: What's Driving Markets Monday?
22 Apr 24
Boston Scientific (BSX) Faces Rising Costs, Competition
11 Apr 24
Philips (PHG) Boosts Patient Monitoring With SmartQare Deal
9 Apr 24
How Is The Market Feeling About Cardinal Health?
8 Apr 24
Press releases
Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
2 Apr 24
Cardinal Health announces approved science-based climate targets; expands focus across the supply chain
15 Mar 24
Cardinal Health annual research report examines milestone year in biosimilars
29 Feb 24
Cardinal Health Board of Directors Approves Quarterly Dividend
6 Feb 24
Cardinal Health publishes Fiscal 2023 Environmental, Social and Governance (ESG) Report
6 Feb 24